tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Viridian Therapeutics (GB:0K1R)
LSE:0K1R
UK Market
0K1R
Viridian Therapeutics
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Viridian Therapeutics (0K1R) Stock News & Sentiment

Compare
1 Followers
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
Premium
Market News
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
2M ago
NKE
NBIX
Viridian Therapeutics Achieves Milestone in Phase 3 Trial
Premium
Company Announcements
Viridian Therapeutics Achieves Milestone in Phase 3 Trial
2M ago
8K
VRDN
Viridian Therapeutics (VRDN) Has Captured Investors’ Attention with Recent Breakthroughs
Premium
Market News
Viridian Therapeutics (VRDN) Has Captured Investors’ Attention with Recent Breakthroughs
3M ago
AMGN
VRDN
Viridian Therapeutics Reports Increased Cash Reserves Amid Losses
Premium
Company Announcements
Viridian Therapeutics Reports Increased Cash Reserves Amid Losses
3M ago
VRDN
Viridian Therapeutics Advances in Biotech Innovations
Premium
Company Announcements
Viridian Therapeutics Advances in Biotech Innovations
3M ago
8K
VRDN
Is VRDN a Buy, Before Earnings?
Premium
Pre-Earnings
Is VRDN a Buy, Before Earnings?
3M ago
VRDN
Viridian Therapeutics’ Veligrotug Triumphs in THRIVE Trial
Premium
Company Announcements
Viridian Therapeutics’ Veligrotug Triumphs in THRIVE Trial
5M ago
8K
VRDN
More GB:0K1R News >

0K1R News on the Web

TANG CAPITAL MANAGEMENT LLC Increases Stake in Nkarta Inc
GuruFocus News
Neutral
Notable Two Hundred Day Moving Average Cross - VRDN
BNK Invest
Neutral
Wedbush stays positive on Viridian shares after Acelyrin data
The Fly
Neutral
Buy Rating Reaffirmed for Viridian Therapeutics: Promising Phase 3 Results for Veligrotug in TED Treatment
TipRanks News
Bullish
TD Cowen Remains a Buy on Viridian Therapeutics (VRDN)
TipRanks News
Bullish
Viridian Therapeutics (VRDN) Gets a Buy from Oppenheimer
TipRanks News
Bullish
Buy Rating for Veligrotug Driven by Positive Phase 3 Results and Competitive Edge Over Amgen’s Tepezza
TipRanks News
Bullish
Viridian Therapeutics’ Veligrotug Outperforms in THRIVE-2 Trial, Boosting Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
GB:0K1R
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0K1R’s Media Buzz Sentiment?
Currently, no data Available
What is GB:0K1R’s weekly average amount of articles?
Currently, no data Available
What is GB:0K1R’s News Sentiment?
59% of articles about GB:0K1R were positive this week, compared to its sector average of 60%.
    Healthcare Stocks that are Trending in the News
    DGXQuest Diagnostics
    PFEPfizer
    VRTXVertex Pharmaceuticals
    CNGGFCann Group Ltd.
    ACLAustralian Clinical Labs Ltd
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing